Protagenic Therapeutics, Inc.
PTIX
$0.92
-$0.11-10.32%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -86.18% | 10,308.28% | -- | -- | -- |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 6.51% | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -83.61% | 1,631.31% | -- | -- | -- |
|
|
|||||
| Total Current Assets | -83.61% | 1,631.31% | -- | -- | -- |
| Net Property, Plant & Equipment | -90.31% | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -0.64% | -- | -- | -- | -- |
| Total Assets | -56.91% | 3,996.97% | -- | -- | -- |
|
|
|||||
| Total Accounts Payable | -52.02% | -1.21% | -- | -- | -- |
| Total Accrued Expenses | -85.59% | -67.08% | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -89.75% | -79.54% | -- | -- | -- |
|
|
|||||
| Total Current Liabilities | -89.75% | -79.54% | -- | -- | -- |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -89.75% | -79.54% | -- | -- | -- |
|
|
|||||
| Common Stock & APIC | 4.74% | 1,434.25% | -- | -- | -- |
| Retained Earnings | 52.24% | 25.34% | -- | -- | -- |
| Treasury Stock & Other | -32.46% | -3,019.09% | -- | -- | -- |
| Total Common Equity | 143.37% | 152.88% | -- | -- | -- |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 143.37% | 152.88% | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 143.37% | 152.88% | -- | -- | -- |
|
|
|||||